Four-year survival rates for patients with metastatic...

Annals of Oncology 2013 / 08 Vol. 24; Iss. 8

Four-year survival rates for patients with metastatic melanoma who received ipilimumab in phase II clinical trials

Wolchok, J. D., Weber, J. S., Maio, M., Neyns, B., Harmankaya, K., Chin, K., Cykowski, L., de Pril, V., Humphrey, R., Lebbe, C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
24
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdt161
Date:
August, 2013
File:
PDF, 170 KB
english, 2013
Conversion to is in progress
Conversion to is failed